What Tx is your first choice for metastatic BRAF+ melanoma?

Mario Sznol*, Jeffrey A. Sosman

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
Number of pages1
JournalOncology Report
Issue numberNOVEMBER-DECEMBER
StatePublished - Nov 1 2011

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this